KOSDAQ - Delayed Quote KRW

CLIO Cosmetics Co.,Ltd (237880.KQ)

Compare
18,700.00
+1,220.00
+(6.98%)
At close: 3:30:23 PM GMT+9
Loading Chart for 237880.KQ
  • Previous Close 17,480.00
  • Open 18,100.00
  • Bid 18,700.00 x --
  • Ask 18,730.00 x --
  • Day's Range 17,980.00 - 18,810.00
  • 52 Week Range 15,790.00 - 45,000.00
  • Volume 110,531
  • Avg. Volume 204,395
  • Market Cap (intraday) 327.71B
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025 - May 12, 2025
  • Forward Dividend & Yield 400.00 (2.05%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est 28,750.00

CLIO Cosmetics Co.,Ltd provides makeup products in South Korea and internationally. It offers eye liner and brow, cushion, lipstick, lip tint, shading, skincare, hair, as well as body and perfumes. The company offers its products under the CLIO, peripera, goodal, DERMATORY, Healing Bird, etc. brands through its CLUB CLIO shopping mall, as well as provides professional services through offline stores and online malls. CLIO Cosmetics Co.,Ltd was founded in 1993 and is based in Seoul, South Korea.

www.clio.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 237880.KQ

View More

Performance Overview: 237880.KQ

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

237880.KQ
8.72%
KOSPI Composite Index (^KS11)
1.90%

1-Year Return

237880.KQ
34.15%
KOSPI Composite Index (^KS11)
9.61%

3-Year Return

237880.KQ
3.26%
KOSPI Composite Index (^KS11)
9.46%

5-Year Return

237880.KQ
0.63%
KOSPI Composite Index (^KS11)
31.41%

Compare To: 237880.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 237880.KQ

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    306.33B

  • Enterprise Value

    177.41B

  • Trailing P/E

    11.28

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.89

  • Price/Book (mrq)

    1.31

  • Enterprise Value/Revenue

    0.50

  • Enterprise Value/EBITDA

    5.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.93%

  • Return on Assets (ttm)

    5.35%

  • Return on Equity (ttm)

    12.13%

  • Revenue (ttm)

    351.37B

  • Net Income Avi to Common (ttm)

    27.86B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    131.24B

  • Total Debt/Equity (mrq)

    0.99%

  • Levered Free Cash Flow (ttm)

    1.14B

Research Analysis: 237880.KQ

View More

Company Insights: 237880.KQ

Research Reports: 237880.KQ

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.